Is MAB1 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6
Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of MAB1 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: MAB1 (£6.42) is trading above our estimate of fair value (£3.63)
Significantly Below Fair Value: MAB1 is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for MAB1?
Key metric: As MAB1 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for MAB1. This is calculated by dividing MAB1's market cap by their current
earnings.
What is MAB1's PE Ratio?
PE Ratio
34.6x
Earnings
UK£10.74m
Market Cap
UK£381.36m
MAB1 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: MAB1 is expensive based on its Price-To-Earnings Ratio (34.6x) compared to the UK Diversified Financial industry average (13.4x).
Price to Earnings Ratio vs Fair Ratio
What is MAB1's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
MAB1 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
34.6x
Fair PE Ratio
18.5x
Price-To-Earnings vs Fair Ratio: MAB1 is expensive based on its Price-To-Earnings Ratio (34.6x) compared to the estimated Fair Price-To-Earnings Ratio (18.5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst MAB1 forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
UK£6.42
UK£9.50
+48.0%
5.3%
UK£10.00
UK£9.00
n/a
2
Nov ’25
UK£7.84
UK£10.25
+30.7%
2.4%
UK£10.50
UK£10.00
n/a
2
Oct ’25
UK£6.64
UK£10.25
+54.4%
2.4%
UK£10.50
UK£10.00
n/a
2
Sep ’25
UK£7.80
UK£10.25
+31.4%
2.4%
UK£10.50
UK£10.00
n/a
2
Aug ’25
UK£9.24
UK£10.25
+10.9%
2.4%
UK£10.50
UK£10.00
n/a
2
Mar ’25
UK£8.30
UK£8.65
+4.2%
4.0%
UK£9.00
UK£8.30
n/a
2
Feb ’25
UK£8.22
UK£8.65
+5.2%
4.0%
UK£9.00
UK£8.30
n/a
2
Jan ’25
UK£8.20
UK£8.15
-0.6%
1.8%
UK£8.30
UK£8.00
n/a
2
Dec ’24
UK£6.84
UK£8.15
+19.2%
1.8%
UK£8.30
UK£8.00
UK£6.30
2
Nov ’24
UK£5.72
UK£8.15
+42.5%
1.8%
UK£8.30
UK£8.00
UK£7.84
2
Oct ’24
UK£5.36
UK£8.25
+53.9%
3.0%
UK£8.50
UK£8.00
UK£6.64
2
Sep ’24
UK£5.96
UK£8.25
+38.4%
3.0%
UK£8.50
UK£8.00
UK£7.80
2
Aug ’24
UK£6.38
UK£8.08
+26.7%
3.9%
UK£8.50
UK£7.75
UK£9.24
3
Jul ’24
UK£5.90
UK£8.08
+37.0%
3.9%
UK£8.50
UK£7.75
UK£8.08
3
Jun ’24
UK£7.12
UK£8.08
+13.5%
3.9%
UK£8.50
UK£7.75
UK£8.90
3
May ’24
UK£7.80
UK£8.08
+3.6%
3.9%
UK£8.50
UK£7.75
UK£8.60
3
Apr ’24
UK£7.42
UK£8.01
+7.9%
2.7%
UK£8.27
UK£7.75
UK£9.12
3
Mar ’24
UK£6.02
UK£8.01
+33.0%
2.7%
UK£8.27
UK£7.75
UK£8.30
3
Feb ’24
UK£6.78
UK£8.01
+18.1%
2.7%
UK£8.27
UK£7.75
UK£8.22
3
Jan ’24
UK£5.30
UK£9.62
+81.6%
21.9%
UK£12.60
UK£8.00
UK£8.20
3
Dec ’23
UK£5.24
UK£12.27
+134.1%
27.4%
UK£16.20
UK£8.00
UK£6.84
3
Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.